ClinicalTrials.govpublic full text
Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months
hand foot and mouth disease, vaccine, safety, immunogenicity, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895174
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.